RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Automated Method for Rapid Detection of Sickle Cell Disease Inhibitors
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
Use of Anthrax Lethal Factor to Treat Cancer and Screening Methods for MAPK Kinase Protease Activity
In vitro and ex vivo methods of screening for modulators, homologues, and mimetics of LF mitogen activated protein kinase kinase (MAPKK) protease activity. More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Epigenetics: Current and future applications that are driving novel drug discovery
Aug 2010 - 80 pages - $1,215
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Biomarkers: Applications and Trends
Aug 2010 - 138 pages - $1,215
Glazer’s Wholesale Drug Company, Inc.: SWOT Analysis & Company Profile
Sep 2010 - 15 pages - $99
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
Glazer's Wholesale Drug Company Inc. - SWOT Analysis
Dec 2010 - 21 pages - $125
Turner Drug Store Ltd. - Company Capsule
Aug 2011 - 7 pages - $75
Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla
Aug 2011 - 5 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us